In an apartment building on the Upper West Side of New York, 74th and Broadway, there is yet another controversy surrounding smoking and non-smoking residents.
Harm Reduction
The science and policy of minimising risks associated with substance use, high-risk behaviours, and public health challenges — grounded in evidence rather than stigma.
A press release in the New York Sun caught ACSH off guard with its negative coverage of Swedish smokeless tobacco, also known as snus.
This week's announcement by Philip Morris that it plans a "global blitz" to dramatically increase the number of cigarette smokers around the world represents the ultimate public health nightmare.
Bupropion, a drug taken for smoking cessation and prescribed most often for adults, is yielding only short-lived results in adolescents according to an article in the November issue of the
November 15th marks the thirty-first annual "Great American Smokeout," a campaign initially undertaken by the American Cancer Society, whose goal was to encourage smokers to quit -- even if only for one day -- hoping this would lead to prolonged a
This piece first appeared in the New York Post
This morning's New York Times op-ed "A Two-Cigarette Society" by attorney David G. Adams made me think I was reading The Onion. Adams argued that we should have two types of cigarettes, one with and one without nicotine.
An article in Skeptic Volume 13, Number 3 by Sidney Zion quotes ACSH's Dr. Elizabeth Whelan on exaggerations about secondhand smoke's effects:
An October 9, 2007 article by Becky Bell on
That the tobacco industry is dead set on increasing its appeal to young people should by now be no news to anyone. What seems to surprise Newsweek columnist Anna Quindlen (Oct.
